We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global Primary Progressive Multiple Sclerosis Treatment Market Analysis 2015-2019 and Forecast 2020-2025

Snapshot
The global Primary Progressive Multiple Sclerosis Treatment market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Primary Progressive Multiple Sclerosis Treatment by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
ApE
Biotin
GZ-402668
Ibudilast
Idebenone
Laquinimod Sodium
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
F. Hoffmann-La Roche Ltd.
Genzyme Corporation
Glialogix, Inc.
Kyorin Pharmaceutical Co., Ltd.
MedDay SA
Santhera Pharmaceuticals Holding AG
Teva Pharmaceutical Industries Ltd.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital
Clinic
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)

Table of Content

1 Industry Overview
1.1 Primary Progressive Multiple Sclerosis Treatment Industry
Figure Primary Progressive Multiple Sclerosis Treatment Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Primary Progressive Multiple Sclerosis Treatment
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Primary Progressive Multiple Sclerosis Treatment
1.2.2 Downstream
Table Application Segment of Primary Progressive Multiple Sclerosis Treatment
Table Global Primary Progressive Multiple Sclerosis Treatment Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Primary Progressive Multiple Sclerosis Treatment Market by Type
3.1 By Type
3.1.1 ApE
Table Major Company List of ApE
3.1.2 Biotin
Table Major Company List of Biotin
3.1.3 GZ-402668
Table Major Company List of GZ-402668
3.1.4 Ibudilast
Table Major Company List of Ibudilast
3.1.5 Idebenone
Table Major Company List of Idebenone
3.1.6 Laquinimod Sodium
Table Major Company List of Laquinimod Sodium
3.1.7 Others
Table Major Company List of Others
3.2 Market Size
Table Global Primary Progressive Multiple Sclerosis Treatment Market 2015-2019, by Type, in USD Million
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Growth 2015-2019, by Type, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market 2015-2019, by Type, in Volume
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Primary Progressive Multiple Sclerosis Treatment Market Forecast 2020-2025, by Type, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
4.1.1 F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Overview List
4.1.2 F. Hoffmann-La Roche Ltd. Products & Services
4.1.3 F. Hoffmann-La Roche Ltd. Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Genzyme Corporation (Company Profile, Sales Data etc.)
4.2.1 Genzyme Corporation Profile
Table Genzyme Corporation Overview List
4.2.2 Genzyme Corporation Products & Services
4.2.3 Genzyme Corporation Business Operation Conditions
Table Business Operation of Genzyme Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Glialogix, Inc. (Company Profile, Sales Data etc.)
4.3.1 Glialogix, Inc. Profile
Table Glialogix, Inc. Overview List
4.3.2 Glialogix, Inc. Products & Services
4.3.3 Glialogix, Inc. Business Operation Conditions
Table Business Operation of Glialogix, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Kyorin Pharmaceutical Co., Ltd. (Company Profile, Sales Data etc.)
4.4.1 Kyorin Pharmaceutical Co., Ltd. Profile
Table Kyorin Pharmaceutical Co., Ltd. Overview List
4.4.2 Kyorin Pharmaceutical Co., Ltd. Products & Services
4.4.3 Kyorin Pharmaceutical Co., Ltd. Business Operation Conditions
Table Business Operation of Kyorin Pharmaceutical Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 MedDay SA (Company Profile, Sales Data etc.)
4.5.1 MedDay SA Profile
Table MedDay SA Overview List
4.5.2 MedDay SA Products & Services
4.5.3 MedDay SA Business Operation Conditions
Table Business Operation of MedDay SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Santhera Pharmaceuticals Holding AG (Company Profile, Sales Data etc.)
4.6.1 Santhera Pharmaceuticals Holding AG Profile
Table Santhera Pharmaceuticals Holding AG Overview List
4.6.2 Santhera Pharmaceuticals Holding AG Products & Services
4.6.3 Santhera Pharmaceuticals Holding AG Business Operation Conditions
Table Business Operation of Santhera Pharmaceuticals Holding AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Teva Pharmaceutical Industries Ltd. (Company Profile, Sales Data etc.)
4.7.1 Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Overview List
4.7.2 Teva Pharmaceutical Industries Ltd. Products & Services
4.7.3 Teva Pharmaceutical Industries Ltd. Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue 2015-2019, by Company, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue Share in 2019, by Company, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Volume 2015-2019, by Company, in Volume
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Concentration, in 2019
Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Market Concentration, in 2019
Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment MMarket Concentration, in 2019
Figure South America Primary Progressive Multiple Sclerosis Treatment Market Concentration, in 2019
Figure Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Hospital, 2015-2019, in USD Million
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Hospital, 2015-2019, in Volume
6.1.2 Demand in Clinic
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Clinic, 2015-2019, in USD Million
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Clinic, 2015-2019, in Volume
6.1.3 Demand in Others
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Others, 2015-2019, in USD Million
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Primary Progressive Multiple Sclerosis Treatment Demand Forecast 2020-2025, by Application, in USD Million
Figure Primary Progressive Multiple Sclerosis Treatment Market Growth 2020-2025, by Application, in USD Million
Figure Primary Progressive Multiple Sclerosis Treatment Market Share in 2025, by Application, in USD Million
Table Primary Progressive Multiple Sclerosis Treatment Demand Forecast 2020-2025, by Application, in Volume
Table Primary Progressive Multiple Sclerosis Treatment Market Growth 2020-2025, by Application, in Volume
Table Primary Progressive Multiple Sclerosis Treatment Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Primary Progressive Multiple Sclerosis Treatment Production 2015-2019, by Region, in USD Million
Table Primary Progressive Multiple Sclerosis Treatment Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Primary Progressive Multiple Sclerosis Treatment Market 2015-2019, by Region, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market Share 2015-2019, by Region, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market 2015-2019, by Region, in Volume
Table Global Primary Progressive Multiple Sclerosis Treatment Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in USD Million
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in USD Million
Table North America Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in USD Million
Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in USD Million
Table Europe Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in USD Million
Figure South America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in USD Million
Table South America Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Primary Progressive Multiple Sclerosis Treatment Market Forecast 2020-2025, by Region, in USD Million
Table Primary Progressive Multiple Sclerosis Treatment Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Tables

List of Table

List of Table

Table Upstream Segment of Primary Progressive Multiple Sclerosis Treatment
Table Application Segment of Primary Progressive Multiple Sclerosis Treatment
Table Global Primary Progressive Multiple Sclerosis Treatment Market 2015-2025, by Application, in USD Million
Table Major Company List of Biotin
Table Major Company List of GZ-402668
Table Major Company List of Ibudilast
Table Major Company List of Idebenone
Table Major Company List of Laquinimod Sodium
Table Major Company List of Others
Table Global Primary Progressive Multiple Sclerosis Treatment Market 2015-2019, by Type, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market 2015-2019, by Type, in Volume
Table Global Primary Progressive Multiple Sclerosis Treatment Market Forecast 2020-2025, by Type, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market Forecast 2020-2025, by Type, in Volume
Table F. Hoffmann-La Roche Ltd. Overview List
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genzyme Corporation Overview List
Table Business Operation of Genzyme Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Glialogix, Inc. Overview List
Table Business Operation of Glialogix, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kyorin Pharmaceutical Co., Ltd. Overview List
Table Business Operation of Kyorin Pharmaceutical Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MedDay SA Overview List
Table Business Operation of MedDay SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Santhera Pharmaceuticals Holding AG Overview List
Table Business Operation of Santhera Pharmaceuticals Holding AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd. Overview List
Table Business Operation of Teva Pharmaceutical Industries Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue 2015-2019, by Company, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Volume 2015-2019, by Company, in Volume
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Primary Progressive Multiple Sclerosis Treatment Demand Forecast 2020-2025, by Application, in USD Million
Table Primary Progressive Multiple Sclerosis Treatment Demand Forecast 2020-2025, by Application, in Volume
Table Primary Progressive Multiple Sclerosis Treatment Market Growth 2020-2025, by Application, in Volume
Table Primary Progressive Multiple Sclerosis Treatment Market Share in 2025, by Application, in Volume
Table Primary Progressive Multiple Sclerosis Treatment Production 2015-2019, by Region, in USD Million
Table Primary Progressive Multiple Sclerosis Treatment Production 2015-2019, by Region, in Volume
Table Global Primary Progressive Multiple Sclerosis Treatment Market 2015-2019, by Region, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market Share 2015-2019, by Region, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market 2015-2019, by Region, in Volume
Table Global Primary Progressive Multiple Sclerosis Treatment Market Share 2015-2019, by Region, in Volume
Table North America Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in USD Million
Table North America Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in Volume
Table Europe Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in USD Million
Table Europe Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in Volume
Table South America Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in USD Million
Table South America Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size 2015-2019, by Country, in Volume
Table Primary Progressive Multiple Sclerosis Treatment Market Forecast 2020-2025, by Region, in USD Million
Table Primary Progressive Multiple Sclerosis Treatment Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List

List of Figures

List of Figure

Figure Primary Progressive Multiple Sclerosis Treatment Industry Chain Structure
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Growth 2015-2019, by Type, in USD Million
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Growth 2015-2019, by Type, in Volume
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue Share in 2019, by Company, in USD Million
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Volume Share in 2019, by Company, in Volume
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Concentration, in 2019
Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Market Concentration, in 2019
Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment MMarket Concentration, in 2019
Figure South America Primary Progressive Multiple Sclerosis Treatment Market Concentration, in 2019
Figure Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Concentration, in 2019
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Hospital, 2015-2019, in USD Million
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Hospital, 2015-2019, in Volume
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Clinic, 2015-2019, in USD Million
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Clinic, 2015-2019, in Volume
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Others, 2015-2019, in USD Million
Figure Primary Progressive Multiple Sclerosis Treatment Demand in Others, 2015-2019, in Volume
Figure Primary Progressive Multiple Sclerosis Treatment Market Growth 2020-2025, by Application, in USD Million
Figure Primary Progressive Multiple Sclerosis Treatment Market Share in 2025, by Application, in USD Million
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in USD Million
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in Volume
Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in USD Million
Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in Volume
Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in Volume
Figure South America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in USD Million
Figure South America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in Volume
Figure Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2019, in Volume
Figure Marketing Channels Overview

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved